Y93-25390-21963
3 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 021 / MA
- Registered
- 2022-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Dose 1 — Pfizer-BioNTech
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2022-01-28
Dose 3 — Pfizer-BioNTech
-
2022-01-29
Registered in v-safe
-
2022-01-29
Survey response — days 1–6 daily, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-30
- 2022-01-31
- 2022-02-01
- 2022-02-02
- 2022-02-04
-
2022-02-25
Survey response — day 28, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: FairFree text: Cough, congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | No |
| 2 | 2021-02-12 | Pfizer-BioNTech | No |
| 3 | 2022-01-28 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Sore throat
Release 11 — day 28, dose 3
Symptoms: Cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release